Peter Sykora, DO
Anesthesiology · Philadelphia, PANPI 1366795080
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Nevro Corp. at 33.1% of the total. Reporting peaked in 2022 at $2,716 and has fallen 88.6% since, to $308 in 2025. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $67.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Medtronic$1K
- Abbott$1K
- Stryker$883
- Curonix LLC$240
- Avanos Medical$131
- plus $34 from 2 others
What the payments were for
- Speaking & faculty fees$89217%
- Travel & lodging$1,94737%
- Food & beverage$2,38645%
- Education$301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 21 | $1,741 |
| Medtronic | 10 | $1,116 |
| Abbott | 34 | $1,110 |
| Stryker | 8 | $883 |
| Curonix LLC | 2 | $240 |
| Avanos Medical | 1 | $131 |
| Merck | 1 | $23 |
| AbbVie | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,254 in reported general payments places this provider in the 95th percentile of 2,015 anesthesiology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 20 | $24,134 |
| Xtampza ErOxycodone Myristate | 32 | $23,469 |
| BelbucaBuprenorphine Hcl | 18 | $16,267 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 262 | $7,961 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 236 | $7,865 |
| Pregabalin | 190 | $5,152 |
| Gabapentin | 319 | $4,348 |
| Oxycodone Hcl | 195 | $3,762 |
| Lidocaine | 16 | $2,616 |
| Buprenorphine | 13 | $1,989 |
| Tramadol Hcl | 148 | $1,604 |
| Cyclobenzaprine Hcl | 133 | $1,270 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 48 | $1,132 |
| Naloxone Hcl | 14 | $1,027 |
| Morphine Sulfate ErMorphine Sulfate | 35 | $708 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Philadelphia
- Lee FleisherPhiladelphia$659K
- Eugene ViscusiPhiladelphia$398K
- Michael ScottPhiladelphia$250K
- Joshua AtkinsPhiladelphia$55K
- Jacob RaphaelPhiladelphia$32K
- Armen VoskeridjianPhiladelphia$26K
- Eleazar MorrisPhiladelphia$19K
- Brian MalonePhiladelphia$15K
- Rebecca BarnettPhiladelphia$14K
- Michael WilliamsPhiladelphia$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.